The global non-invasive prenatal testing market is anticipated to reach USD 5.5 billion by 2025, according to a new report by Grand View Research, Inc. Evolution of prenatal testing in the form of noninvasive tests that can serve as an intermediate step between serum screening and invasive diagnostic testing to determine the likelihood of fetal abnormality is expected to drive growth in the reproductive genetics industry over the forecast period.
In addition, presence of payers such as Anthem and Blue Shield of California that have endorsed cfDNA-based Noninvasive Prenatal Testing (NIPT) for trisomies 13, 18, and 21 is expected to impact the adoption rate of these tests, thereby resulting in increased revenue generation.
However, the projected NIPT-related price erosion in this market is expected to continue, thus intensifying competition amongst the operating participants, but restraining revenue generation to a certain extent.
Browse Details of Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/noninvasive-prenatal-testing-market
Key Takeaways from the report:
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/1840/ibb
Grand View Research has segmented the NIPT market on the basis of gestation period, and pregnancy risk level:
Noninvasive Prenatal Testing Outlook, by Gestation Period (Revenue, USD Million, 2014 – 2025)
Noninvasive Prenatal Testing Outlook, by Pregnancy Risk Level (Revenue, USD Million, 2014 – 2025)
Noninvasive Prenatal Testing Regional Outlook (Revenue, USD Million, 2014 – 2025)
Browse Related Reports :
Tissue Diagnostics Market Analysis Report By Technology (Immunohistochemistry, In Situ Hybridization, Digital & Anatomic Pathology), By Application, By End Use, And Segment Forecasts, 2019 – 2025
https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market
Sepsis Diagnostics Market Size Analysis Report By Pathogen (Bacterial, Fungal), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Product, By Testing Type, And Segment Forecasts, 2019 – 2026
https://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: https://www.grandviewresearch.com/industry-analysis/noninvasive-prenatal-testing-market